Sanofi Urges High Court To Expand Arthrex To All

By Hailey Konnath (July 6, 2020, 11:21 PM EDT) -- Sanofi-Aventis has urged the U.S. Supreme Court to weigh in on its patent row with Mylan, arguing in a recent petition that the Federal Circuit's decision that the structure of the Patent Trial and Appeal Board is unconstitutional should now apply to all companies, even those that didn't raise the underlying constitutional issue in their briefs....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!